BRIGHTHOUSE LIFE INSURANCE Co OF NY 10-Q 2019 Q3 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___                

Commission File Number: 000-55705

Brighthouse Life Insurance Company of NY

(Exact name of registrant as specified in its charter)

New York				13-3690700
(State or other jurisdiction of incorporation or organization)				(I.R.S. Employer Identification No.)
	285 Madison Avenue, 14th Floor,	New York,	New York	10017
(Address of principal executive offices)				(Zip Code)

(980) 365-7100

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class Trading symbol(s) Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ    No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes þ    No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	þ	Smaller reporting company		☐
		Emerging growth company		☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐    No��þ

As of November 6, 2019, 200,000 shares of the registrant’s common stock were outstanding, all of which were owned indirectly by Brighthouse Financial, Inc.

REDUCED DISCLOSURE FORMAT

The registrant meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q and is, therefore, filing this Form 10-Q with the reduced disclosure format.

Table of Contents

		Page
Part I — Financial Information
Item 1.	Financial Statements (at September 30, 2019 (Unaudited) and December 31, 2018 and for the Three Months and Nine Months Ended September 30, 2019 and 2018 (Unaudited)):
	Interim Condensed Balance Sheets	2
	Interim Condensed Statements of Operations and Comprehensive Income (Loss)	3
	Interim Condensed Statements of Stockholder’s Equity	4
	Interim Condensed Statements of Cash Flows	5
	Notes to the Interim Condensed Financial Statements (Unaudited):
	Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies	6
	Note 2 — Segment Information	8
	Note 3 — Insurance	11
	Note 4 — Investments	12
	Note 5 — Derivatives	18
	Note 6 — Fair Value	24
	Note 7 — Equity	33
	Note 8 — Other Revenues and Other Expenses	35
	Note 9 — Contingencies, Commitments and Guarantees	36
	Note 10 — Related Party Transactions	37
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	40
Item 4.	Controls and Procedures	49
Part II — Other Information
Item 1.	Legal Proceedings	49
Item 1A.	Risk Factors	49
Item 6.	Exhibits	50
Signatures		51

Part I — Financial Information

Item 1. Financial Statements

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Balance Sheets

September 30, 2019 (Unaudited) and December 31, 2018

(In thousands, except share and per share data)

	September 30, 2019		December 31, 2018
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $2,837,125 and $2,469,801, respectively)	$	3,023,679	$	2,433,633
Mortgage loans (net of valuation allowances of $2,419 and $1,937, respectively)	562,241		448,105
Other invested assets, principally at estimated fair value	29,276		35,815
Total investments	3,615,196		2,917,553
Cash and cash equivalents	165,538		120,130
Accrued investment income	44,731		20,605
Premiums, reinsurance and other receivables	678,840		580,480
Deferred policy acquisition costs and value of business acquired	160,627		185,586
Current income tax recoverable	10,791		—
Other assets	31,731		37,348
Separate account assets	4,533,701		4,268,423
Total assets	$	9,241,155	$	8,130,125
Liabilities and Stockholder's Equity
Liabilities
Future policy benefits	$	742,320	$	718,599
Policyholder account balances	2,155,849		1,692,498
Other policy-related balances	12,662		9,288
Payables for collateral under derivative transactions	27,322		23,581
Current income tax payable	—		1,755
Deferred income tax liability	168,148		107,853
Other liabilities	496,686		471,490
Separate account liabilities	4,533,701		4,268,423
Total liabilities	8,136,688		7,293,487
Contingencies, Commitments and Guarantees (Note 9)
Stockholder's Equity
Common stock, par value $10 per share; 200,000 shares authorized, issued and outstanding	2,000		2,000
Additional paid-in capital	490,931		415,931
Retained earnings (deficit)	478,305		433,778
Accumulated other comprehensive income (loss)	133,231		(15,071		)
Total stockholder's equity	1,104,467		836,638
Total liabilities and stockholder's equity	$	9,241,155	$	8,130,125

See accompanying notes to the interim condensed financial statements.

2

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Operations and Comprehensive Income (Loss)

For the Three Months and Nine Months Ended September 30, 2019 and 2018 (Unaudited)

(In thousands)

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2019			2018			2019			2018
Revenues
Premiums	$	5,249		$	8,112		$	21,247		$	27,517
Universal life and investment-type product policy fees	24,814			25,515			72,207			77,384
Net investment income	31,861			25,264			88,070			73,284
Other revenues	(21,330		)	(13,217		)	(63,361		)	(37,837		)
Net investment gains (losses)	(1,200		)	(330		)	3,820			(4,748		)
Net derivative gains (losses)	50,606			(27,153		)	74,669			(92,527		)
Total revenues	90,000			18,191			196,652			43,073
Expenses
Policyholder benefits and claims	14,002			(1,347		)	37,849			1,060
Interest credited to policyholder account balances	9,117			9,577			26,508			28,146
Amortization of deferred policy acquisition costs and value of business acquired	14,847			4,085			21,310			2,257
Other expenses	19,754			18,764			58,268			50,672
Total expenses	57,720			31,079			143,935			82,135
Income (loss) before provision for income tax	32,280			(12,888		)	52,717			(39,062		)
Provision for income tax expense (benefit)	5,229			(4,404		)	8,190			(11,247		)
Net income (loss)	$	27,051		$	(8,484	)	$	44,527		$	(27,815	)
Comprehensive income (loss)	$	68,582		$	(22,013	)	$	192,829		$	(86,762	)

See accompanying notes to the interim condensed financial statements.

3

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Stockholder’s Equity

For the Three Months and Nine Months Ended September 30, 2019 and 2018 (Unaudited)

(In thousands)

	Common Stock		Additional Paid-in Capital		Retained Earnings (Deficit)		Accumulated Other Comprehensive Income (Loss)			Total Stockholder’s Equity
Balance at December 31, 2018	$	2,000	$	415,931	$	433,778	$	(15,071	)	$	836,638
Capital contribution			75,000							75,000
Net income (loss)					17,476					17,476
Other comprehensive income (loss), net of income tax							106,771			106,771
Balance at June 30, 2019	2,000		490,931		451,254		91,700			1,035,885
Net income (loss)					27,051					27,051
Other comprehensive income (loss), net of income tax							41,531			41,531
Balance at September 30, 2019	$	2,000	$	490,931	$	478,305	$	133,231		$	1,104,467

	Common Stock		Additional Paid-in Capital		Retained Earnings (Deficit)			Accumulated Other Comprehensive Income (Loss)			Total Stockholder’s Equity
Balance at December 31, 2017	$	2,000	$	415,931	$	395,928		$	29,628		$	843,487
Net income (loss)					(19,331		)				(19,331		)
Other comprehensive income (loss), net of income tax								(45,418		)	(45,418		)
Balance at June 30, 2018	2,000		415,931		376,597			(15,790		)	778,738
Net income (loss)					(8,484		)				(8,484		)
Other comprehensive income (loss), net of income tax								(13,529		)	(13,529		)
Balance at September 30, 2018	$	2,000	$	415,931	$	368,113		$	(29,319	)	$	756,725

See accompanying notes to the interim condensed financial statements.

4

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Cash Flows

For the Nine Months Ended September 30, 2019 and 2018 (Unaudited)

(In thousands)

	Nine Months Ended   September 30,
	2019			2018
Net cash provided by (used in) operating activities	$	(6,578	)	$	86,693
Cash flows from investing activities
Sales, maturities and repayments of:
Fixed maturity securities	537,957			214,723
Mortgage loans	20,354			6,226
Purchases of:
Fixed maturity securities	(877,954		)	(460,830		)
Mortgage loans	(134,795		)	(34,094		)
Cash received in connection with freestanding derivatives	72,495			5,792
Cash paid in connection with freestanding derivatives	(10,369		)	(39,942		)
Net change in other invested assets	6,337			379
Net cash provided by (used in) investing activities	(385,975		)	(307,746		)
Cash flows from financing activities
Policyholder account balances:
Deposits	475,330			331,880
Withdrawals	(116,143		)	(87,402		)
Net change in payables for collateral under derivative transactions	3,741			30,701
Capital contribution	75,000			—
Financing element on certain derivative instruments and other derivative related transactions, net	33			—
Net cash provided by (used in) financing activities	437,961			275,179
Change in cash, cash equivalents and restricted cash	45,408			54,126
Cash, cash equivalents and restricted cash, beginning of period	120,130			86,154
Cash, cash equivalents and restricted cash, end of period	$	165,538		$	140,280
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Income tax	$	1		$	12

See accompanying notes to the interim condensed financial statements.

5

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“BHNY” and the “Company” refer to Brighthouse Life Insurance Company of NY, a New York domiciled life insurance company. Brighthouse Life Insurance Company of NY is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (“BHF” together with its subsidiaries and affiliates, “Brighthouse Financial”). The Company is licensed to transact business in the state of New York.

BHNY markets and/or administers traditional life, universal life, variable annuity and fixed annuity products to individuals. The Company is organized into 2 segments: Annuities; and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

In 2016, MetLife, Inc. (together with its subsidiaries and affiliates, “MetLife”) announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). In connection with the Separation, 80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Reclassifications

Certain amounts in the prior year periods’ interim condensed financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Financial Statements.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

The accompanying interim condensed financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 balance sheet data was derived from audited financial statements included in Brighthouse Life Insurance Company of NY’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed financial statements should be read in conjunction with the financial statements of the Company included in the 2018 Annual Report.

Adoption of New Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during 2019 that had a material impact on the Company’s financial statements.

6

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

ASUs issued but not yet adopted as of September 30, 2019 are summarized in the table below.

Standard	Description	Effective Date	Impact on Financial Statements
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts	The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs (“DAC”), and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances. The market risk benefit guidance is required to be applied on a retrospective basis, while the changes to guidance for insurance liabilities and DAC may be applied to existing carrying amounts on the effective date or on a retrospective basis.	The amendments were originally effective on January 1, 2021. On October 16, 2019, the FASB voted to change the effective date of the ASU to January 1, 2022.	The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments	The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.	January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)	The impact upon adoption is not expected to be material.

7

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information

The Company is organized into 2 segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

Annuities

The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

Life

The Life segment consists of insurance products and services, including term, whole and universal life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.

Corporate & Other

Corporate & Other contains the excess capital not allocated to the segments and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s former U.S. insurance business sold direct to consumers, which is no longer being offered for new sales.

Financial Measures and Segment Accounting Policies

Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings should not be viewed as a substitute for net income (loss).

Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and

• Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).

The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

• Amounts associated with benefits related to GMIBs (“GMIB Costs”);

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and

• Amortization of DAC and value of business acquired related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.

The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate.

The segment accounting policies are the same as those used to prepare the Company’s condensed financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.

Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess

8

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information (continued)

capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital. Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets.

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months and nine months ended September 30, 2019 and 2018.

	Operating Results
Three Months Ended September 30, 2019	Annuities			Life			Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	(13,103	)	$	(4,095	)	$	151		$	(17,047	)
Provision for income tax expense (benefit)	(2,986		)	(861		)	(1,284		)	(5,131		)
Adjusted earnings	$	(10,117	)	$	(3,234	)	$	1,435		(11,916		)
Adjustments for:
Net investment gains (losses)										(1,200		)
Net derivative gains (losses)										50,606
Other adjustments to net income										(79		)
Provision for income tax (expense) benefit										(10,360		)
Net income (loss)										$	27,051
Interest revenue	$	21,493		$	9,789		$	682

	Operating Results
Three Months Ended September 30, 2018	Annuities		Life		Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	12,592	$	5,596	$	(3,687	)	$	14,501
Provision for income tax expense (benefit)	1,881		1,173		(1,066		)	1,988
Adjusted earnings	$	10,711	$	4,423	$	(2,621	)	12,513
Adjustments for:
Net investment gains (losses)								(330		)
Net derivative gains (losses)								(27,153		)
Other adjustments to net income								94
Provision for income tax (expense) benefit								6,392
Net income (loss)								$	(8,484	)
Interest revenue	$	16,236	$	8,662	$	461

9

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information (continued)

	Operating Results
Nine Months Ended September 30, 2019	Annuities			Life			Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	(25,054	)	$	(14,279	)	$	(1,551	)	$	(40,884	)
Provision for income tax expense (benefit)	(6,340		)	(2,999		)	(2,128		)	(11,467		)
Adjusted earnings	$	(18,714	)	$	(11,280	)	$	577		(29,417		)
Adjustments for:
Net investment gains (losses)										3,820
Net derivative gains (losses)										74,669
Other adjustments to net income										15,112
Provision for income tax (expense) benefit										(19,657		)
Net income (loss)										$	44,527
Interest revenue	$	59,372		$	27,399		$	1,589

	Operating Results
Nine Months Ended September 30, 2018	Annuities		Life		Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	24,496	$	18,166	$	(1,240	)	$	41,422
Provision for income tax expense (benefit)	3,418		3,815		(939		)	6,294
Adjusted earnings	$	21,078	$	14,351	$	(301	)	35,128
Adjustments for:
Net investment gains (losses)								(4,748		)
Net derivative gains (losses)								(92,527		)
Other adjustments to net income								16,791
Provision for income tax (expense) benefit								17,541
Net income (loss)								$	(27,815	)
Interest revenue	$	46,317	$	25,983	$	1,257

The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
	2019		2018			2019		2018
	(In thousands)
Annuities	$	22,044	$	26,098		$	65,751	$	81,842
Life	14,224		15,079			40,348		45,182
Corporate & Other	1,058		1,120			2,256		3,223
Adjustments	52,674		(24,106		)	88,297		(87,174		)
Total	$	90,000	$	18,191		$	196,652	$	43,073

10

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information (continued)

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	September 30, 2019		December 31, 2018
	(In thousands)
Annuities	$	8,003,389	$	7,034,394
Life	1,177,511		1,083,641
Corporate & Other	60,255		12,090
Total	$	9,241,155	$	8,130,125

3. Insurance

Guarantees

As discussed in Notes 1 and 3 of the Notes to the Financial Statements included in the 2018 Annual Report, the Company issues variable annuity contracts with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”), the non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”) and certain portions of GMIBs that do not require the policyholder to annuitize are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 5.

Information regarding the Company’s guarantee exposure was as follows at:

	September 30, 2019						December 31, 2018
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in thousands)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	4,539,418		$	3,651,540		$	4,274,326		$	3,483,668
Separate account value	$	4,531,579		$	3,651,158		$	4,266,520		$	3,482,829
Net amount at risk	$	10,247	(4)	$	329,920	(5)	$	193,102	(4)	$	274,632	(5)
Average attained age of contract holders	68 years			68 years			67 years			67 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the net amount at risk presented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 5 of the Notes to the Financial Statements included in the 2018 Annual Report for a discussion of guaranteed minimum benefits which have been reinsured.

(3) Includes the contract holder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

11

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments

See Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for a description of the Company’s accounting policies for investments and Note 6 for information about the fair value hierarchy for investments and the related valuation methodologies.

Fixed Maturity Securities Available-for-sale (“AFS”)

Fixed Maturity Securities AFS by Sector

The following table presents the fixed maturity securities AFS by sector at:

	September 30, 2019										December 31, 2018
	Amortized Cost		Gross Unrealized						Estimated Fair Value		Amortized Cost		Gross Unrealized						Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses						Gains		Temporary Losses		OTTI Losses
	(In thousands)
Fixed maturity securities:
U.S. corporate	$	1,333,210	$	86,339	$	1,639	$	—	$	1,417,910	$	890,676	$	5,402	$	23,034	$	—	$	873,044
U.S. government and agency	290,315		37,566		—		—		327,881		511,255		9,961		13,697		—		507,519
Foreign corporate	393,919		20,634		4,274		—		410,279		368,149		1,473		17,258		—		352,364
CMBS	321,766		20,885		90		—		342,561		325,491		1,481		4,121		—		322,851
RMBS	296,859		14,215		1,070		—		310,004		200,827		4,643		2,882		—		202,588
ABS	95,336		920		445		—		95,811		79,806		158		1,133		—		78,831
State and political subdivision	85,587		11,602		39		—		97,150		66,131		4,777		1,083		—		69,825
Foreign government	20,133		2,021		71		—		22,083		27,466		140		995		—		26,611
Total fixed maturity securities	$	2,837,125	$	194,182	$	7,628	$	—	$	3,023,679	$	2,469,801	$	28,035	$	64,203	$	—	$	2,433,633

The Company held 0 non-income producing fixed maturity securities at either September 30, 2019 or December 31, 2018.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at September 30, 2019:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities (1)		Total Fixed Maturity Securities
	(In thousands)
Amortized cost	$	66,292	$	355,561	$	928,414	$	772,897	$	713,961	$	2,837,125
Estimated fair value	$	66,775	$	364,591	$	981,126	$	862,811	$	748,376	$	3,023,679

__________________

(1) Structured securities include commercial mortgage-backed securities (“CMBS”), residential mortgage-backed securities (“RMBS”), and asset-backed securities (“ABS”) (collectively, “Structured Securities”).

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

12

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	September 30, 2019								December 31, 2018
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in thousands)
Fixed maturity securities:
U.S. corporate	$	58,009	$	1,131	$	34,657	$	508	$	483,424	$	15,849	$	131,812	$	7,185
U.S. government and agency	—		—		—		—		102,447		1,925		296,265		11,772
Foreign corporate	30,549		936		27,262		3,338		194,924		10,156		72,803		7,102
CMBS	19		—		7,347		90		119,412		1,909		44,775		2,212
RMBS	8,433		96		7,907		974		57,510		1,746		28,573		1,136
ABS	26,851		111		14,815		334		51,028		985		11,699		148
State and political subdivision	12,670		39		—		—		18,260		744		13,999		339
Foreign government	944		71		—		—		7,435		716		6,782		279
Total fixed maturity securities	$	137,475	$	2,384	$	91,988	$	5,244	$	1,034,440	$	34,030	$	606,708	$	30,173
Total number of securities in an unrealized loss position	55				40				364				146

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

For securities in an unrealized loss position, an OTTI is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in other comprehensive income (“OCI”).

13

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at September 30, 2019.

Gross unrealized losses on fixed maturity securities decreased $56.6 million during the nine months ended September 30, 2019 to $7.6 million. The decrease in gross unrealized losses for the nine months ended September 30, 2019 was primarily attributable to decreasing longer-term interest rates and narrowing credit spreads.

At September 30, 2019, $939 thousand of the total $7.6 million of gross unrealized losses were from 1 fixed maturity security with an unrealized loss position of 20% or more of amortized cost for six months or greater.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	September 30, 2019					December 31, 2018
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in thousands)
Mortgage loans:
Commercial	$	403,516		71.8	%	$	310,681		69.3	%
Agricultural	161,144			28.6		139,361			31.1
Subtotal	564,660			100.4		450,042			100.4
Valuation allowances (1)	(2,419		)	(0.4	)	(1,937		)	(0.4	)
Total mortgage loans, net	$	562,241		100.0	%	$	448,105		100.0	%

__________________

(1) The valuation allowances were primarily from collective evaluation (non-specific loan related).

Information on commercial and agricultural mortgage loans is presented in the tables below.

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

14

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in thousands)
September 30, 2019
Loan-to-value ratios:
Less than 65%	$	369,937	$	5,100	$	—	$	375,037	92.9	%
65% to 75%	24,206		—		—		24,206		6.0
76% to 80%	4,273		—		—		4,273		1.1
Total	$	398,416	$	5,100	$	—	$	403,516	100.0	%
December 31, 2018
Loan-to-value ratios:
Less than 65%	$	273,681	$	5,000	$	13,447	$	292,128	94.0	%
65% to 75%	14,257		—		—		14,257		4.6
76% to 80%	4,296		—		—		4,296		1.4
Total	$	292,234	$	5,000	$	13,447	$	310,681	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at: 

	September 30, 2019				December 31, 2018
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in thousands)
Loan-to-value ratios:
Less than 65%	$	150,027	93.1	%	$	133,884	96.1	%
65% to 75%	11,117		6.9		5,477		3.9
Total	$	161,144	100.0	%	$	139,361	100.0	%

Past Due, Nonaccrual and Modified Mortgage Loans

The Company has a high quality, well performing mortgage loan portfolio, with all mortgage loans classified as performing at both September 30, 2019 and December 31, 2018. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company had 0 commercial or agricultural mortgage loans past due or in nonaccrual status at either September 30, 2019 or December 31, 2018. During the three months and nine months ended September 30, 2019 and 2018, the Company had 0 mortgage loans modified in a troubled debt restructuring.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, deferred sales inducements (“DSI”) and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (“AOCI”).

15

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	September 30, 2019			December 31, 2018
	(In thousands)
Fixed maturity securities	$	186,554		$	(36,166	)
Derivatives	11,189			5,791
Subtotal	197,743			(30,375		)
Amounts allocated from:
Future policy benefits	(5,896		)	—
DAC and DSI	(23,199		)	11,299
Deferred income tax benefit (expense)	(35,417		)	4,005
Net unrealized investment gains (losses)	$	133,231		$	(15,071	)

The changes in net unrealized investment gains (losses) were as follows:

	Nine Months Ended   September 30, 2019
	(In thousands)
Balance, December 31, 2018	$	(15,071	)
Unrealized investment gains (losses) during the period	228,118
Unrealized investment gains (losses) relating to:
Future policy benefits	(5,896		)
DAC and DSI	(34,498		)
Deferred income tax benefit (expense)	(39,422		)
Balance, September 30, 2019	$	133,231
Change in net unrealized investment gains (losses)	$	148,302

Concentrations of Credit Risk

There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both September 30, 2019 and December 31, 2018.

Invested Assets on Deposit and Pledged as Collateral

Invested assets on deposit and pledged as collateral are presented below at estimated fair value:

	September 30, 2019		December 31, 2018
	(In thousands)
Invested assets on deposit (regulatory deposits)	$	1,676	$	1,482
Invested assets pledged as collateral (1)	8,380		158
Total invested assets on deposit and pledged as collateral (2)	$	10,056	$	1,640

__________________

(1) The Company has pledged invested assets in connection with derivative transactions (see Note 5).

(2) The Company held 0 restricted cash at either September 30, 2019 or December 31, 2018.

Variable Interest Entities

The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.

16

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

There were 0 material VIEs for which the Company has concluded that it is the primary beneficiary at September 30, 2019 or December 31, 2018.

The Company’s investments in unconsolidated VIEs are described below.

Fixed Maturity Securities

The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.

The carrying amount and maximum exposure to loss related to the VIEs in which the Company concluded that it holds a variable interest, but is not the primary beneficiary, were as follows at:

	September 30, 2019				December 31, 2018
	Carrying Amount		Maximum Exposure to Loss		Carrying Amount		Maximum Exposure to Loss
	(In thousands)
Fixed maturity securities	$	412,339	$	389,432	$	409,699	$	409,699

Net Investment Income

The components of net investment income were as follows:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
	2019		2018		2019		2018
	(In thousands)
Investment income:
Fixed maturity securities	$	25,892	$	21,645	$	73,590	$	62,947
Mortgage loans	5,590		4,392		14,408		12,897
Policy loans	4		2		4		3
Cash, cash equivalents and short-term investments	1,075		393		2,227		849
Other	132		239		843		560
Subtotal	32,693		26,671		91,072		77,256
Less: Investment expenses	832		1,407		3,002		3,972
Net investment income	$	31,861	$	25,264	$	88,070	$	73,284

See “— Related Party Investment Transactions” for discussion of related party investment expenses.

17

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2019			2018			2019			2018
	(In thousands)
Fixed maturity securities	$	(984	)	$	(119	)	$	4,210		$	(5,081	)
Mortgage loans	(277		)	(218		)	(482		)	(165		)
Other	61			7			92			498
Total net investment gains (losses)	$	(1,200	)	$	(330	)	$	3,820		$	(4,748	)

Gains (losses) from foreign currency transactions included within net investment gains (losses) were ($57) thousand and ($54) thousand for the three months and nine months ended September 30, 2019, respectively, and ($13) thousand and $279 thousand for the three months and nine months ended September 30, 2018, respectively.

Sales or Disposals of Fixed Maturity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2019			2018			2019			2018
	(In thousands)
Proceeds	$	41,741		$	995		$	455,423		$	127,671
Gross investment gains	$	530		$	—		$	7,181		$	36
Gross investment losses	(1,514		)	(119		)	(2,971		)	(5,117		)
Net investment gains (losses)	$	(984	)	$	(119	)	$	4,210		$	(5,081	)

Related Party Investment Transactions

The Company receives investment administrative services from MetLife Investment Management, LLC (formerly known as MetLife Investment Advisors, LLC), which was considered a related party investment manager until the completion of the MetLife Divestiture. The related investment administrative service charges were $0 and $2.3 million for the three months and nine months ended September 30, 2018, respectively. All of the charges reported as related party activity in 2018 occurred prior to the MetLife Divestiture. See Note 1 regarding the MetLife Divestiture.

5. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated or did not qualify as an accounting hedge, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).The Company generally reports cash received or paid for a derivative in the investing activity section of the statement of cash flows except for cash flows of certain derivative options with deferred premiums, which are reported in the financing activity section of the statement of cash flows.

18

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

Hedge Accounting

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative or hedged item expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). The changes in estimated fair value of derivatives previously recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item. When the hedged item matures or is sold, or the forecasted transaction is not probable of occurring, the Company immediately reclassifies any remaining balances in OCI to net derivative gains (losses).

Embedded Derivatives

The Company has certain insurance and reinsurance contracts that contain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. These host contracts include: variable annuities with guaranteed minimum benefits; index-linked annuities that are directly written; and ceded reinsurance of variable annuity with guaranteed minimum benefits. Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets. Changes in the estimated fair value of the embedded derivative are reported in net derivative gains (losses).

Derivative Strategies

The Company maintains an overall risk management strategy that incorporates the use of derivative instruments to minimize its exposure to various market risks, including interest rate, foreign currency exchange rate and equity market.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates and/or financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. The Company’s OTC derivatives are settled bilateral contracts between two counterparties (“OTC-bilateral”).

Interest Rate Derivatives

Interest rate caps: The Company uses interest rate caps to protect against interest rate exposure arising from mismatches between assets and liabilities. Interest rate caps are used in nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

Foreign currency swaps: The Company uses foreign currency swaps to convert foreign currency denominated cash flows to U.S. dollars to reduce cash flow fluctuations due to changes in currency exchange rates. Foreign currency swaps are used in cash flow and nonqualifying hedging relationships.

Equity Derivatives

Equity index options: The Company uses equity index options to hedge index-linked annuity products against adverse changes in equity markets. Equity index options are used in nonqualifying hedging relationships.

19

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

Primary Risks Managed by Derivatives

The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, held at:

		September 30, 2019							December 31, 2018
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value					Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities					Assets		Liabilities
		(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency swaps	Foreign currency exchange rate	$	93,809	$	10,775	$	—		$	82,704	$	5,649	$	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate caps	Interest rate	800,000		1,765		—			800,000		9,284		—
Foreign currency swaps	Foreign currency exchange rate	17,892		5,235		—			28,133		3,395		144
Equity index options	Equity market	1,525,992		10,749		17,352			2,154,321		10,389		96
Total non-designated or nonqualifying derivatives		2,343,884		17,749		17,352			2,982,454		23,068		240
Embedded derivatives:
Ceded guaranteed minimum income benefits	Other	N/A		402,674		—			N/A		298,112		—
Direct guaranteed minimum benefits	Other	N/A		—		(211		)	N/A		—		(18,811		)
Direct index-linked annuities	Other	N/A		—		103,500			N/A		—		5,617
Total embedded derivatives	Other	N/A		402,674		103,289			N/A		298,112		(13,194		)
Total		$	2,437,693	$	431,198	$	120,641		$	3,065,158	$	326,829	$	(12,767	)

20

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

The following tables present the amount and location of gains (losses), including earned income, recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives			Net Derivative Gains (Losses) Recognized for Hedged Items			Net Investment Income		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended September 30, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency exchange rate derivatives	$	—		$	—		$	138	$	2,330
Total cash flow hedges	—			—			138		2,330
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(1,160		)	—			—		—
Foreign currency exchange rate derivatives	1,213			(130		)	—		—
Equity derivatives	(4,556		)	—			—		—
Embedded derivatives	55,239			—			—		—
Total non-qualifying hedges	50,736			(130		)	—		—
Total	$	50,736		$	(130	)	$	138	$	2,330
Three Months Ended September 30, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency exchange rate derivatives	$	3		$	9		$	239	$	65
Total cash flow hedges	3			9			239		65
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	414			—			—		—
Foreign currency exchange rate derivatives	49			(52		)	—		—
Equity derivatives	8,914			—			—		—
Embedded derivatives	(36,490		)	—			—		—
Total non-qualifying hedges	(27,113		)	(52		)	—		—
Total	$	(27,110	)	$	(43	)	$	239	$	65

21

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

	Net Derivative Gains (Losses) Recognized for Derivatives			Net Derivative Gains (Losses) Recognized for Hedged Items			Net Investment Income		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Nine Months Ended September 30, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency exchange rate derivatives	$	3		$	(14	)	$	761	$	5,401
Total cash flow hedges	3			(14		)	761		5,401
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(7,519		)	—			—		—
Foreign currency exchange rate derivatives	2,268			(132		)	—		—
Equity derivatives	45,131			—			—		—
Embedded derivatives	34,932			—			—		—
Total non-qualifying hedges	74,812			(132		)	—		—
Total	$	74,815		$	(146	)	$	761	$	5,401
Nine Months Ended September 30, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency exchange rate derivatives	$	58		$	9		$	640	$	967
Total cash flow hedges	58			9			640		967
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(3,576		)	—			—		—
Foreign currency exchange rate derivatives	342			(156		)	—		—
Equity derivatives	1,900			—			—		—
Embedded derivatives	(91,104		)	—			—		—
Total non-qualifying hedges	(92,438		)	(156		)	—		—
Total	$	(92,380	)	$	(147	)	$	640	$	967

At September 30, 2019 and December 31, 2018, the balance in AOCI associated with cash flow hedges was $11.2 million and $5.8 million, respectively.

Counterparty Credit Risk

The Company may be exposed to credit-related losses in the event of counterparty nonperformance on derivative instruments. Generally, the credit exposure is the fair value at the reporting date less any collateral received from the counterparty.

The Company manages its credit risk by: (i) entering into derivative transactions with creditworthy counterparties governed by master netting agreements; (ii) trading through regulated exchanges and central clearing counterparties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.

See Note 6 for a description of the impact of credit risk on the valuation of derivatives.

22

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: 

			Gross Amounts Not Offset on the Balance Sheets
	Gross Amount Recognized		Financial Instruments (1)			Collateral Received/Pledged (2)			Net Amount		Off-balance Sheet Securities Collateral (3)			Net Amount After Securities Collateral
	(In thousands)
September 30, 2019
Derivative assets	$	28,937	$	(10,742	)	$	(14,722	)	$	3,473	$	(3,394	)	$	79
Derivative liabilities	$	17,352	$	(10,742	)	$	—		$	6,610	$	(6,610	)	$	—
December 31, 2018
Derivative assets	$	29,006	$	(365	)	$	(23,197	)	$	5,444	$	(2,212	)	$	3,232
Derivative liabilities	$	411	$	(365	)	$	—		$	46	$	(46	)	$	—

__________________

(1) Represents amounts subject to an enforceable master netting agreement or similar agreement.

(2) The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreement.

(3) Securities collateral received by the Company is not recorded on the balance sheet. Amounts do not include excess of collateral pledged or received.

The Company’s collateral arrangements generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. Certain of these arrangements also include credit contingent provisions which permit the party with positive fair value to terminate the derivative at the current fair value or demand immediate full collateralization from the party in a net liability position, in the event that the financial strength or credit rating of the party in a net liability position falls below a certain level.

The following table presents the aggregate estimated fair value of derivatives in a net liability position containing such credit contingent provisions and the aggregate estimated fair value of assets posted as collateral for such instruments.

	September 30, 2019		December 31, 2018
	(In thousands)
Estimated fair value of derivatives in a net liability position (1)	$	6,610	$	46
Estimated Fair Value of Collateral Provided (2):
Fixed maturity securities	$	8,379	$	158

__________________

(1) After taking into consideration the existence of netting agreements.

(2) Substantially all of the Company’s collateral arrangements provide for daily posting of collateral for the full value of the derivative contract. As a result, if the credit contingent provisions of derivative contracts in a net liability position were triggered, minimal additional assets would be required to be posted as collateral or needed to settle the instruments immediately.

23

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, are presented below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.

	September 30, 2019
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	1,403,471	$	14,439	$	1,417,910
U.S. government and agency	188,414		139,467		—		327,881
Foreign corporate	—		393,633		16,646		410,279
CMBS	—		342,561		—		342,561
RMBS	—		310,004		—		310,004
ABS	—		90,511		5,300		95,811
State and political subdivision	—		97,150		—		97,150
Foreign government	—		22,083		—		22,083
Total fixed maturity securities	188,414		2,798,880		36,385		3,023,679
Derivative assets: (1)
Interest rate	—		1,765		—		1,765
Foreign currency exchange rate	—		16,010		—		16,010
Equity market	—		10,749		—		10,749
Total derivative assets	—		28,524		—		28,524
Embedded derivatives within asset host contracts (2)	—		—		402,674		402,674
Separate account assets	—		4,533,701		—		4,533,701
Total assets	$	188,414	$	7,361,105	$	439,059	$	7,988,578
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	—	$	—	$	—
Equity market	—		17,352		—		17,352
Total derivative liabilities	—		17,352		—		17,352
Embedded derivatives within liability host contracts (2)	—		—		103,289		103,289
Total liabilities	$	—	$	17,352	$	103,289	$	120,641

24

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

	December 31, 2018
	Fair Value Hierarchy
	Level 1		Level 2		Level 3			Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	869,498	$	3,546		$	873,044
U.S. government and agency	389,491		118,028		—			507,519
Foreign corporate	—		342,600		9,764			352,364
CMBS	—		318,120		4,731			322,851
RMBS	—		202,588		—			202,588
ABS	—		78,831		—			78,831
State and political subdivision	—		69,825		—			69,825
Foreign government	—		26,611		—			26,611
Total fixed maturity securities	389,491		2,026,101		18,041			2,433,633
Derivative assets: (1)
Interest rate	—		9,284		—			9,284
Foreign currency exchange rate	—		8,572		472			9,044
Equity market	—		10,389		—			10,389
Total derivative assets	—		28,245		472			28,717
Embedded derivatives within asset host contracts (2)	—		—		298,112			298,112
Separate account assets	—		4,268,423		—			4,268,423
Total assets	$	389,491	$	6,322,769	$	316,625		$	7,028,885
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	331	$	—		$	331
Equity market	—		96		—			96
Total derivative liabilities	—		427		—			427
Embedded derivatives within liability host contracts (2)	—		—		(13,194		)	(13,194		)
Total liabilities	$	—	$	427	$	(13,194	)	$	(12,767	)

______________

(1) Derivative assets are presented within other invested assets on the balance sheets and derivative liabilities are presented within other liabilities on the balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets.

Valuation Controls and Procedures

The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards.

25

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The fair value of financial assets and financial liabilities is based on quoted market prices, where available. The Company assesses whether prices received represent a reasonable estimate of fair value through controls designed to ensure valuations represent an exit price. Valuation service providers perform several controls, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.

Valuation service providers also apply a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, valuation service providers will use the last available price.

The Company reviews outputs of the valuation service providers’ controls and performs additional controls, including certain monthly controls, which include but are not limited to, performing balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the nine months ended September 30, 2019.

Determination of Fair Value

Fixed Maturity Securities

The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.

U.S. corporate and foreign corporate securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.

U.S. government and agency, state and political subdivision and foreign government securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker dealer quotes, and comparable securities that are actively traded.

Structured Securities: Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.

26

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

Derivatives

The fair values for OTC-bilateral derivatives classified as Level 2 assets or liabilities are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.

The significant inputs to the pricing models for most OTC-bilateral derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. 

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Embedded Derivatives

Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the balance sheets.

The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

27

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.

Transfers Into or Out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					September 30, 2019			December 31, 2018			Impact of Increase in Input on Estimated Fair Value
	Valuation Techniques		Significant Unobservable Inputs		Range			Range
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates	0.02%	-	11.31%	0.02%	-	11.31%	Decrease (1)
			•	Lapse rates	0.25%	-	16.00%	0.25%	-	16.00%	Decrease (2)
			•	Utilization rates	0.00%	-	25.00%	0.00%	-	25.00%	Increase (3)
			•	Withdrawal rates	0.25%	-	10.00%	0.25%	-	10.00%	(4)
			•	Long-term equity volatilities	16.50%	-	22.00%	16.50%	-	22.00%	Increase (5)
			•	Nonperformance risk spread	0.61%	-	2.37%	1.91%	-	2.66%	Decrease (6)

______________

(1) Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.

(2) Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.

(3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.

28

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

(4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

29

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			Net Derivatives (2)		Net Embedded Derivatives (3)
	(In thousands)
Three Months Ended September 30, 2019
Balance, beginning of period	$	21,421		$	—		$	—	$	260,473
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	9			—			—		55,239
Total realized/unrealized gains (losses) included in AOCI	4			—			—		—
Purchases (6)	10,741			5,300			—		—
Sales (6)	(83		)	—			—		—
Issuances (6)	—			—			—		—
Settlements (6)	—			—			—		(16,327		)
Transfers into Level 3 (7)	—			—			—		—
Transfers out of Level 3 (7)	(1,007		)	—			—		—
Balance, end of period	$	31,085		$	5,300		$	—	$	299,385
Three Months Ended September 30, 2018
Balance, beginning of period	$	95,245		$	26,162		$	—	$	281,185
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	4			51			—		(36,490		)
Total realized/unrealized gains (losses) included in AOCI	(1,278		)	88			—		—
Purchases (6)	—			3,000			—		—
Sales (6)	(606		)	(417		)	—		—
Issuances (6)	—			—			—		—
Settlements (6)	—			—			—		(6,201		)
Transfers into Level 3 (7)	—			—			—		—
Transfers out of Level 3 (7)	(9,500		)	(4,500		)	—		—
Balance, end of period	$	83,865		$	24,384		$	—	$	238,494
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2019 (8)	$	9		$	—		$	—	$	50,269
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2018 (8)	$	4		$	51		$	—	$	(8,229	)

30

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			Net Derivatives (2)			Net Embedded Derivatives (3)
	(In thousands)
Nine Months Ended September 30, 2019
Balance, beginning of period	$	13,310		$	4,731		$	472		$	311,306
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	27			—			—			34,932
Total realized/unrealized gains (losses) included in AOCI	199			—			—			—
Purchases (6)	18,741			5,300			—			—
Sales (6)	(195		)	—			—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(46,853		)
Transfers into Level 3 (7)	262			—			—			—
Transfers out of Level 3 (7)	(1,259		)	(4,731		)	(472		)	—
Balance, end of period	$	31,085		$	5,300		$	—		$	299,385
Nine Months Ended September 30, 2018
Balance, beginning of period	$	95,950		$	19,557		$	—		$	347,633
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	(216		)	237			—			(91,104		)
Total realized/unrealized gains (losses) included in AOCI	(5,024		)	296			—			—
Purchases (6)	1,753			5,401			—			—
Sales (6)	(5,432		)	(1,107		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(18,035		)
Transfers into Level 3 (7)	—			—			—			—
Transfers out of Level 3 (7)	(3,166		)	—			—			—
Balance, end of period	$	83,865		$	24,384		$	—		$	238,494
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2019 (8)	$	27		$	—		$	—		$	89,329
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2018 (8)	$	12		$	237		$	—		$	(56,866	)

______________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

(5) Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.

(6) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

31

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

(7) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(8) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under derivative transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	September 30, 2019
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	562,241	$	—	$	—	$	588,195	$	588,195
Premiums, reinsurance and other receivables	$	14,885	$	—	$	334	$	14,243	$	14,577
Liabilities
Policyholder account balances	$	979,845	$	—	$	—	$	977,640	$	977,640
Other liabilities	$	49,057	$	—	$	49,057	$	—	$	49,057

	December 31, 2018
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	448,105	$	—	$	—	$	447,510	$	447,510
Premiums, reinsurance and other receivables	$	20,001	$	—	$	2,314	$	15,512	$	17,826
Liabilities
Policyholder account balances	$	1,056,419	$	—	$	—	$	949,916	$	949,916
Other liabilities	$	10,399	$	—	$	10,399	$	—	$	10,399

32

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

7. Equity

Capital Transactions

During the first quarter of 2019, the Company received a cash capital contribution of $75 million from Brighthouse Life Insurance Company.

Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI was as follows:

	Three Months Ended   September 30, 2019
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, June 30, 2019	$	83,844		$	7,856		$	91,700
OCI before reclassifications	49,440			2,330			51,770
Deferred income tax benefit (expense)	(10,383		)	(489		)	(10,872		)
AOCI before reclassifications, net of income tax	122,901			9,697			132,598
Amounts reclassified from AOCI	802			—			802
Deferred income tax benefit (expense)	(169		)	—			(169		)
Amounts reclassified from AOCI, net of income tax	633			—			633
Balance, September 30, 2019	$	123,534		$	9,697		$	133,231

	Three Months Ended   September 30, 2018
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, June 30, 2018	$	(16,765	)	$	975		$	(15,790	)
OCI before reclassifications	(17,301		)	65			(17,236		)
Deferred income tax benefit (expense)	3,634			(14		)	3,620
AOCI before reclassifications, net of income tax	(30,432		)	1,026			(29,406		)
Amounts reclassified from AOCI	113			(3		)	110
Deferred income tax benefit (expense)	(23		)	—			(23		)
Amounts reclassified from AOCI, net of income tax	90			(3		)	87
Balance, September 30, 2018	$	(30,342	)	$	1,023		$	(29,319	)

33

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

7. Equity (continued)

	Nine Months Ended   September 30, 2019
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2018	$	(20,503	)	$	5,432		$	(15,071	)
OCI before reclassifications	186,708			5,401			192,109
Deferred income tax benefit (expense)	(39,209		)	(1,134		)	(40,343		)
AOCI before reclassifications, net of income tax	126,996			9,699			136,695
Amounts reclassified from AOCI	(4,382		)	(3		)	(4,385		)
Deferred income tax benefit (expense)	920			1			921
Amounts reclassified from AOCI, net of income tax	(3,462		)	(2		)	(3,464		)
Balance, September 30, 2019	$	123,534		$	9,697		$	133,231

	Nine Months Ended   September 30, 2018
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2017	$	29,323		$	305		$	29,628
OCI before reclassifications	(80,593		)	967			(79,626		)
Deferred income tax benefit (expense)	16,923			(203		)	16,720
AOCI before reclassifications, net of income tax	(34,347		)	1,069			(33,278		)
Amounts reclassified from AOCI	5,069			(58		)	5,011
Deferred income tax benefit (expense)	(1,064		)	12			(1,052		)
Amounts reclassified from AOCI, net of income tax	4,005			(46		)	3,959
Balance, September 30, 2018	$	(30,342	)	$	1,023		$	(29,319	)

______________

(1) See Note 4 for information on offsets to investments related to DAC and DSI.

34

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

7. Equity (continued)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI												Statements of Operations and Comprehensive Income (Loss) Locations
	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2019			2018			2019			2018
	(In thousands)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	(802	)	$	(120	)	$	4,396		$	(5,082	)	Net investment gains (losses)
Net unrealized investment gains (losses)	—			7			—			13			Net investment income
Net unrealized investment gains (losses)	—			—			(14		)	—			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(802		)	(113		)	4,382			(5,069		)
Income tax (expense) benefit	169			23			(920		)	1,064
Net unrealized investment gains (losses), net of income tax	(633		)	(90		)	3,462			(4,005		)
Unrealized gains (losses) on derivatives - cash flow hedges:
Foreign currency swaps	—			3			3			58			Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	—			3			3			58
Income tax (expense) benefit	—			—			(1		)	(12		)
Gains (losses) on cash flow hedges, net of income tax	—			3			2			46
Total reclassifications, net of income tax	$	(633	)	$	(87	)	$	3,464		$	(3,959	)

8. Other Revenues and Other Expenses

Other Revenues

The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.

To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.

Other revenues consisted primarily of 12b-1 fees of $3.2 million and $9.5 million for the three months and nine months ended September 30, 2019, respectively, and $3.4 million and $10.3 million for the three months and nine months ended September 30, 2018, respectively, of which all were reported in the Annuities segment.

35

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

8. Other Revenues and Other Expenses (continued)

Other Expenses

Information on other expenses was as follows:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
	2019		2018		2019		2018
	(In thousands)
Compensation	$	4,713	$	3,028	$	14,153	$	10,218
Contracted services and other labor costs	3,797		2,456		9,833		6,978
Transition services agreements	3,688		2,706		11,215		8,471
Establishment costs	786		3,913		3,627		3,913
Premium and other taxes, licenses and fees	430		835		481		2,620
Volume related costs, excluding compensation, net of DAC capitalization	4,308		4,553		13,022		14,363
Other	2,032		1,273		5,937		4,109
Total other expenses	$	19,754	$	18,764	$	58,268	$	50,672

Related Party Expenses

See Note 10 for a discussion of related party expenses included in the table above.

9. Contingencies, Commitments and Guarantees

Contingencies

Litigation

Sales Practices Claims

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s net income or cash flows in particular quarterly or annual periods.

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $6.0 million and $7.6 million at September 30, 2019 and December 31, 2018, respectively.

36

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

9. Contingencies, Commitments and Guarantees (continued)

Commitments to Fund Private Corporate Bond Investments

The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $3.5 million and $11.4 million at September 30, 2019 and December 31, 2018, respectively.

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company had 0 liability for indemnities, guarantees and commitments at both September 30, 2019 and December 31, 2018.

10. Related Party Transactions

The Company has various existing arrangements with its Brighthouse affiliates and had previous arrangements with MetLife for services necessary to conduct its activities. Certain of the MetLife services have continued, however, MetLife was no longer considered a related party upon the completion of the MetLife Divestiture on June 14, 2018 (see Note 1). The Company has related party investment and equity transactions (see Notes 4 and 7). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows:

Reinsurance Agreements

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

37

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

10. Related Party Transactions (continued)

Information regarding the significant effects of related party reinsurance included on the interim condensed statements of operations and comprehensive income (loss) was as follows:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2019			2018			2019			2018
	(In thousands)
Premiums
Reinsurance ceded	$	(10,889	)	$	(9,310	)	$	(31,875	)	$	(27,036	)
Universal life and investment-type product policy fees
Reinsurance ceded	$	(701	)	$	(894	)	$	(2,494	)	$	(2,810	)
Other revenues
Reinsurance ceded	$	(24,580	)	$	(16,683	)	$	(73,086	)	$	(48,109	)
Policyholder benefits and claims
Reinsurance ceded	$	(6,531	)	$	(19,476	)	$	(32,489	)	$	(65,970	)

Information regarding the significant effects of ceded related party reinsurance included on the interim condensed balance sheets was as follows at:

	September 30, 2019		December 31, 2018
	(In thousands)
Assets
Premiums, reinsurance and other receivables	$	630,767	$	534,487
Liabilities
Other liabilities	$	399,722	$	429,656

The Company cedes risks to Brighthouse Life Insurance Company related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in the estimated fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were $402.7 million and $298.1 million at September 30, 2019 and December 31, 2018, respectively. Net derivative gains (losses) associated with the embedded derivatives were $71.8 million and $103.2 million for the three months and nine months ended September 30, 2019, respectively, and ($28.3) million and ($99.7) million for the three months and nine months ended September 30, 2018, respectively.

Shared Services and Overhead Allocations

Brighthouse affiliates currently provide and previously MetLife provided the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. Costs incurred under these arrangements with Brighthouse affiliates, as well as with MetLife prior to the MetLife Divestiture, were $14.8 million and $45.1 million for the three months and nine months ended September 30, 2019, respectively, and $15.3 million and $35.2 million for the three months and nine months ended September 30, 2018, respectively, and were recorded in other expenses. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $3.0 million and $8.8 million for the three months and nine months ended September 30, 2019, respectively, and $3.1 million and $9.4 million for the three months and nine months ended September 30, 2018, respectively.

The Company had net receivables (payables) from/to affiliates, related to the items discussed above, of ($3.0) million and $622 thousand at September 30, 2019 and December 31, 2018, respectively.

38

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

10. Related Party Transactions (continued)

Brighthouse affiliates incur costs related to the establishment of services and infrastructure to replace those previously provided by MetLife. The Company is charged a fee to reflect the value of the available infrastructure and services provided by these costs. While management believes the method used to allocate expenses under this arrangement is reasonable, the allocated expenses may not be indicative of those of a stand-alone entity. If expenses were allocated to the Company under this arrangement as incurred by Brighthouse affiliates, the Company would not have incurred additional expenses for the three months and nine months ended September 30, 2019. The Company would have incurred additional expenses of $1.1 million and $2.2 million under this arrangement for the three months and nine months ended September 30, 2018, respectively.

Broker-Dealer Transactions

The related party expense for the Company was commissions paid on the sale of variable products and passed through to the broker-dealer affiliate. The related party revenue for the Company was fee income passed through the broker-dealer affiliate from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received related to these transactions and recorded in other revenues was $3.0 million and $8.8 million for the three months and nine months ended September 30, 2019, respectively, and $3.1 million and $9.4 million for the three months and nine months ended September 30, 2018, respectively. Commission expenses incurred related to these transactions and recorded in other expenses was $17.0 million and $48.7 million for the three months and nine months ended September 30, 2019, respectively, and $14.0 million and $39.3 million for the three months and nine months ended September 30, 2018, respectively. The Company also had related party fee income receivables of $969 thousand and $951 thousand at September 30, 2019 and December 31, 2018, respectively.

39

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Page
Introduction	41
Overview	41
Regulatory Developments	41
Summary of Critical Accounting Estimates	42
Non-GAAP and Other Financial Disclosures	42
Results of Operations	45
Note Regarding Forward-Looking Statements	48

40

Introduction

For purposes of this discussion, unless otherwise mentioned or unless the context indicates otherwise, “BHNY,” the “Company,” “we,” “our” and “us” refer to Brighthouse Life Insurance Company of NY (formerly, First MetLife Investors Insurance Company), a New York domiciled life insurance company. BHNY is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (together with its subsidiaries and affiliates, “Brighthouse”). Management’s narrative analysis of the results of operations is presented pursuant to General Instruction H(2)(a) of Form 10-Q. This narrative analysis should be read in conjunction with (i) the unaudited interim condensed financial statements and related notes included elsewhere herein; (ii) our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 6, 2019 (the “2018 Annual Report”); (iii) our Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 (the “First Quarter Form 10-Q”) filed with the SEC on May 9, 2019; (iv) our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 (the “Second Quarter Form 10-Q”) filed with the SEC on August 8, 2019; and (v) our current reports on Form 8-K filed in 2019.

The term “Separation” refers to the separation of MetLife, Inc.’s (together with its subsidiaries and affiliates, “MetLife”) former Brighthouse Financial segment from MetLife’s other businesses and the creation of a separate, publicly traded company, Brighthouse Financial, Inc. (we use the term “BHF” to refer solely to Brighthouse Financial, Inc., and not to any of its subsidiaries), as well as the distribution on August 4, 2017 of 96,776,670, or 80.8%, of the 119,773,106 shares of BHF common stock outstanding immediately prior to the distribution date by MetLife, Inc. to holders of MetLife, Inc. common stock as of the record date for the distribution. The term “MetLife Divestiture” refers to the disposition by MetLife, Inc. on June 14, 2018 of all its remaining shares of BHF common stock. Effective with the MetLife Divestiture, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties to BHF and its subsidiaries and affiliates.

Overview

We offer a range of individual annuities and individual life insurance products in New York. For operating purposes, we have established two segments: Annuities and Life. In addition, we report certain of our results of operations in Corporate & Other. See “Business — Segments and Corporate & Other” included in the 2018 Annual Report along with Note 2 of the Notes to the Interim Condensed Financial Statements for further information on our segments and Corporate & Other.

See Note 1 of the Notes to the Interim Condensed Financial Statements for information regarding the adoption of new accounting pronouncements in 2019.

Regulatory Developments

We are domiciled in New York and regulated by the New York State Department of Financial Services. We are regulated primarily at the state level, with some products and services also subject to federal regulation. Furthermore, some of our operations, products and services are subject to the Employee Retirement Income Security Act of 1974 (“ERISA”), consumer protection laws, securities, broker-dealer and investment advisor regulations, as well as environmental and unclaimed property laws and regulations. See “Business — Regulation,” as well as “Risk Factors — Regulatory and Legal Risks” included in our 2018 Annual Report, as amended or supplemented herein and in our Second Quarter Form 10-Q under the headings “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Overview — NAIC” and “— Standard of Conduct Regulation.”

41

Standard of Conduct Regulation

As a result of overlapping efforts by the Department of Labor (the “DOL”), the National Association of Insurance Commissioners, individual states, and the SEC to impose fiduciary-like requirements in connection with the sale of annuities, life insurance policies and securities, there have been a number of proposed or adopted changes to the laws and regulations that govern the conduct of our business and the firms that distribute our products. While we manufacture annuity and life insurance products, we do not directly distribute our products to consumers. However, regulations establishing standards of conduct in connection with the distribution and sale of these products could affect our business by imposing greater compliance, oversight, disclosure and notification requirements on our distributors and/or us, which may in either case increase our costs or limit distribution of our products. Earlier this year, the DOL indicated that it may issue a new proposed rule on fiduciary investment advice under ERISA in 2019. At this time, we cannot predict the content or form of any such rule or its impact on our business, results of operations and financial condition. See “Business — Regulation — Standard of Conduct Regulation — Department of Labor Fiduciary Rule” and “Risk Factors — Regulatory and Legal Risks — Our business is highly regulated, and changes in regulation and in supervisory and enforcement policies may materially impact our capitalization or cash flows, reduce our profitability and limit our growth” in our 2018 Annual Report.

Summary of Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Financial Statements.

The most critical estimates include those used in determining: 

(i) liabilities for future policy benefits;

(ii) accounting for reinsurance;

(iii) capitalization and amortization of deferred policy acquisition costs (“DAC”) and amortization of value of business acquired (“VOBA”);

(iv) estimated fair values of investments in the absence of quoted market values;

(v) investment impairments;

(vi) estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;

(vii) measurement of income taxes and the valuation of deferred tax assets; and

(viii) liabilities for litigation and regulatory matters.

In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.

The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” and Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report.

Non-GAAP and Other Financial Disclosures

Our definitions of the non-GAAP and other financial measures may differ from those used by other companies.

Non-GAAP Financial Disclosures

Adjusted Earnings

In this report, we present adjusted earnings as a measure of our performance that is not calculated in accordance with GAAP. We believe that this non-GAAP financial measure highlights our results of operations and the underlying profitability drivers of our business, as well as enhances the understanding of our performance by the investor community. However, adjusted earnings should not be viewed as a substitute for net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP. See “— Results of Operations” for a reconciliation of adjusted earnings to net income (loss).

42

Adjusted earnings, which may be positive or negative, is used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. This financial measure focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and

• Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).

The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

• Amounts associated with benefits related to GMIBs (“GMIB Costs”);

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and

• Amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.

The tax impact of the adjustments mentioned is calculated net of the statutory tax rate, which could differ from our effective tax rate.

We present adjusted earnings in a manner consistent with management’s view of the primary business activities that drive the profitability of our core businesses. The following table illustrates how each component of adjusted earnings is calculated from the GAAP statement of operations line items:

Component of Adjusted Earnings		How Derived from GAAP (1)
(i)	Fee income	(i)	Universal life and investment-type policy fees (excluding (a) unearned revenue adjustments related to net investment gains (losses) and net derivative gains (losses) and (b) GMIB Fees) plus Other revenues (excluding other revenues associated with related party reinsurance) and amortization of deferred gain on reinsurance.
(ii)	Net investment spread	(ii)	Net investment income plus Investment Hedge Adjustments and interest received on ceded fixed annuity reinsurance deposit funds reduced by Interest credited to policyholder account balances and interest on future policy benefits.
(iii)	Insurance-related activities	(iii)	Premiums less Policyholder benefits and claims (excluding (a) GMIB Costs, (b) Market Value Adjustments, (c) interest on future policy benefits and (d) amortization of deferred gain on reinsurance) plus the pass through of performance of ceded separate account assets.
(iv)	Amortization of DAC and VOBA	(iv)	Amortization of DAC and VOBA (excluding amounts related to (a) net investment gains (losses), (b) net derivative gains (losses), (c) GMIB Fees and GMIB Costs and (d) Market Value Adjustments).
(v)	Other expenses, net of DAC capitalization	(v)	Other expenses reduced by capitalization of DAC.
(vi)	Provision for income tax expense (benefit)	(vi)	Tax impact of the above items.

______________

(1) Italicized items indicate GAAP statement of operations line items.

Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance. Accordingly, we report adjusted earnings by segment in Note 2 of the Notes to the Interim Condensed Financial Statements.

Other Financial Disclosures

43

We sometimes refer to sales activity for various products. Statistical sales information for life sales are calculated using the LIMRA (Life Insurance Marketing and Research Association) definition of sales for core direct sales, excluding company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. Annuity sales consist of 10% of direct statutory premiums, excluding company-sponsored internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

44

Results of Operations

Results for the Nine Months Ended September 30, 2019 and 2018

Business Overview. Annuity sales increased 43% compared to the first nine months of 2018 driven by sales of our structured annuities consisting of products marketed under various names (collectively, “Shield Annuities” or “Shield”).

A significant portion of our net income is driven by separate account balances related to our variable annuity business. Most directly, these balances determine asset-based fee income, but they also impact DAC amortization and asset-based commissions. Separate account balances are driven by sales, movements in the market, surrenders, withdrawals, benefit payments, transfers and policy charges. Variable annuities separate account balances increased for the nine months ended September 30, 2019, compared to December 31, 2018, driven by positive equity market performance, partially offset by negative net flows and policy charges.

Unless otherwise noted, all amounts in the following discussions of our results of operations are stated before income tax except for adjusted earnings, which are presented net of income tax.

	Nine Months Ended   September 30,
	2019			2018
	(In thousands)
Revenues
Premiums	$	21,247		$	27,517
Universal life and investment-type product policy fees	72,207			77,384
Net investment income	88,070			73,284
Other revenues	(63,361		)	(37,837		)
Net investment gains (losses)	3,820			(4,748		)
Net derivative gains (losses)	74,669			(92,527		)
Total revenues	196,652			43,073
Expenses
Policyholder benefits and claims	37,849			1,060
Interest credited to policyholder account balances	26,508			28,146
Capitalization of DAC	(28,851		)	(21,611		)
Amortization of DAC and VOBA	21,310			2,257
Other expenses	87,119			72,283
Total expenses	143,935			82,135
Income (loss) before provision for income tax	52,717			(39,062		)
Provision for income tax expense (benefit)	8,190			(11,247		)
Net income (loss)	$	44,527		$	(27,815	)

45

The table below shows the components of net income (loss).

	Nine Months Ended   September 30,
	2019			2018
	(In thousands)
GMLB Riders	$	95,263		$	(72,610	)
Other derivative instruments	(5,684		)	(3,596		)
Net investment gains (losses)	3,820			(4,748		)
Other adjustments	202			470
Pre-tax adjusted earnings	(40,884		)	41,422
Income (loss) before provision for income tax	52,717			(39,062		)
Provision for income tax expense (benefit)	8,190			(11,247		)
Net income (loss)	$	44,527		$	(27,815	)

Nine Months Ended September 30, 2019 Compared with the Nine Months Ended September 30, 2018

Net income before provision for income tax was $52.7 million ($44.5 million, net of income tax), an increase of $91.8 million ($72.3 million, net of income tax) from a loss before provision for income tax of $39.1 million ($27.8 million, net of income tax) in the prior period.

The increase in income before provision for income tax was primarily due to:

• net favorable changes in guaranteed minimum living benefits (“GMLB”) riders (“GMLB Riders”) driven by:

◦ favorable changes in the estimated fair value of our ceded variable annuity riders, primarily driven by lower interest rates, net of the impact of higher relative equity markets;

◦ favorable changes in freestanding equity derivative positions that hedge the liability reserves for Shield Annuities,

partially offset by

◦ unfavorable changes in variable annuity liability reserves due to lower interest rates net of higher relative equity markets;

◦ unfavorable changes in Shield liability reserves due to higher relative equity markets; and

• favorable changes in net investment gains (losses) reflecting gains in the current period, compared to losses in the prior period, from the sale of fixed maturity securities.

The decrease in the loss before provision for income tax was partially offset by lower adjusted earnings discussed in greater detail below.

The provision for income tax in the current period led to an effective tax rate of 16%, compared to 29% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

46

Reconciliation of Net Income (Loss) to Adjusted Earnings

	Nine Months Ended   September 30,
	2019			2018
	(In thousands)
Net income (loss)	$	44,527		$	(27,815	)
Add: Provision for income tax expense (benefit)	8,190			(11,247		)
Income (loss) before provision for income tax	52,717			(39,062		)
Less: GMLB Riders	95,263			(72,610		)
Less: Other derivative instruments	(5,684		)	(3,596		)
Less: Net investment gains (losses)	3,820			(4,748		)
Less: Other adjustments	202			470
Pre-tax adjusted earnings	(40,884		)	41,422
Less: Provision for income tax expense (benefit)	(11,467		)	6,294
Adjusted earnings	$	(29,417	)	$	35,128

Results for the Nine Months Ended September 30, 2019 and 2018 — Adjusted Earnings

The following table presents the components of adjusted earnings:

	Nine Months Ended   September 30,
	2019			2018
	(In thousands)
Fee income	$	101,257		$	111,166
Net investment spread	47,425			31,902
Insurance-related activities	(100,170		)	(33,035		)
Amortization of DAC and VOBA	(31,128		)	(17,939		)
Other expenses, net of DAC capitalization	(58,268		)	(50,672		)
Pre-tax adjusted earnings	(40,884		)	41,422
Provision for income tax expense (benefit)	(11,467		)	6,294
Adjusted earnings	$	(29,417	)	$	35,128

Nine Months Ended September 30, 2019 Compared with the Nine Months Ended September 30, 2018

Adjusted earnings were a loss of $29.4 million, a decrease of $64.5 million.

Key net unfavorable impacts were:

• higher costs associated with insurance-related activities due to:

◦ unfavorable changes in the estimated fair value of the underlying ceded separate account assets under a related party reinsurance agreement for certain variable annuity contracts;

◦ higher severity of paid claims net of reinsurance; and

◦ higher reserves in the current period on yearly renewable term business reinsured to an affiliate;

• higher amortization of DAC and VOBA in our annuity business primarily driven by changes in the long-term general account earned rate in connection with our third quarter annual actuarial review;

• lower fee income due to lower asset-based fees resulting from lower average separate account balances; and

• higher other expenses due to an increase in the allocation of corporate expenses.

The decrease in adjusted earnings was partially offset by higher net investment spread, reflecting higher average invested assets resulting from positive net flows in the general account.

47

The provision for income tax in the current period led to an effective tax rate of 28%, compared to 15% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

Note Regarding Forward-Looking Statements

This report, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as “anticipate,” “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operating and financial results, as well as statements regarding the expected benefits of the Separation.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of BHNY. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others:

• differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models;

• higher risk management costs and exposure to increased market and counterparty risk due to guarantees within certain of our products;

• the potential material adverse effect of changes in accounting standards, practices and/or policies applicable to us including changes in the accounting for long-duration contracts;

• the effect adverse capital and credit market conditions may have on our ability to meet liquidity needs and our access to capital;

• the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations;

• the effectiveness of our risk management policies and procedures;

• the availability of reinsurance and the ability of our counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder;

• heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, financial strength ratings, e-business capabilities and name recognition;

• our ability to market and distribute our products through distribution channels;

• any failure of third parties to provide services we need, any failure of the practices and procedures of these third parties and any inability to obtain information or assistance we need from third parties, including MetLife;

• whether all or any portion of the tax consequences of the Separation are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us;

• the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements, including the potential of outcomes adverse to us that could cause us to owe MetLife material tax reimbursements or payments, or disagreements regarding MetLife’s or our obligations under our other agreements;

• the impact on our business structure, profitability, cost of capital and flexibility due to restrictions we have agreed to that preserve the tax-free treatment of certain parts of the Separation;

• the potential material negative tax impact of potential future tax legislation that could decrease the value of our tax attributes and cause other cash expenses, such as reserves, to increase materially and make some of our products less attractive to consumers;

48

• whether the Separation will qualify for non-recognition treatment for federal income tax purposes and potential indemnification to MetLife if the Separation does not so qualify;

• the impact of the Separation on our business and profitability due to MetLife’s strong brand and reputation, the increased costs related to replacing arrangements with MetLife with those of third parties and incremental costs as a public company;

• whether the operational, strategic and other benefits of the Separation can be achieved, and our ability to implement our business strategy;

• our ability to attract and retain key personnel; and

• other factors described from time to time in documents that we file with the SEC.

For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our 2018 Annual Report, our subsequent Quarterly Reports on Form 10-Q, particularly in the sections entitled “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk,” as well as in our other subsequent filings with the SEC. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

Item 4. Controls and Procedures

Management, with the participation of the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of September 30, 2019.

MetLife provides certain services to the Company on a transitional basis through services agreements. The Company continues to change business processes, implement systems and establish new third-party arrangements, as a subsidiary of Brighthouse Financial, Inc. We consider these to be material changes in our internal control over financial reporting.

Other than as noted above, there were no changes to the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Part II — Other Information

Item 1. Legal Proceedings

See Note 9 of the Notes to the Interim Condensed Financial Statements included in this report. There have been no new material legal proceedings and no material developments in legal proceedings previously disclosed in the 2018 Annual Report.

Item 1A. Risk Factors

We discuss in this report, in the 2018 Annual Report and in our other filings with the SEC, various risks that may materially affect our business. In addition, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Note Regarding Forward-Looking Statements” included in this report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2018 Annual Report, as amended or supplemented by such information in our subsequent Quarterly Reports on Form 10-Q.

49

Item 6. Exhibits

(Note Regarding Reliance on Statements in Our Contracts: In reviewing the agreements included as exhibits herein, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Brighthouse Life Insurance Company of NY, its affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Brighthouse Life Insurance Company of NY may be found elsewhere herein and Brighthouse Life Insurance Company of NY’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)

Exhibit No.	Description
10.1	First Amended and Restated Investment Management Agreement, dated as of July 17, 2019, by and between Brighthouse Services, LLC and MetLife Investment Management, LLC (Incorporated by reference to Exhibit 10.1 to Form 10-Q, filed by Brighthouse Life Insurance Company of NY on August 8, 2019).
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
104*	The cover page of Brighthouse Life Insurance Company of NY’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, formatted in Inline XBRL (included within the Exhibit 101 attachments).

* Filed herewith.

** Furnished herewith.

50

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY
By:		/s/ Lynn A. Dumais
	Name:	Lynn A. Dumais
	Title:	Vice President and Chief Financial Officer
		(Authorized Signatory and Principal Financial Officer)

Date: November 6, 2019

51